Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MPGN type I induced by granulocyte colony stimulating factor.

Daniella Magen1, Hana Mandel, Moshe Berant

  • 1Pediatric Nephrology Unit, Rambam Medical Center, P.O. Box 9602, Haifa 31096, Israel. d_magen@rambam.health.gov.il

Pediatric Nephrology (Berlin, Germany)
|June 4, 2002
PubMed
Summary

Long-term granulocyte-colony stimulating factor (G-CSF) therapy in a child with severe congenital neutropenia was linked to kidney damage. Reversible renal issues suggest G-CSF may induce membranoproliferative glomerulonephritis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When Atypical Becomes Typical: A Fulminant Seronegative Anti-GBM Disease.

Kidney medicine·2026
Same author

Temporary mycophenolate discontinuation and reintroduction in pediatric kidney transplantation: predictors and long-term outcomes.

Pediatric nephrology (Berlin, Germany)·2026
Same author

IKAROS Associated Immunodeficiency and Thrombotic Thrombocytopenic Purpura.

Pediatric blood & cancer·2025
Same author

Natural History of Advanced Primary Hyperoxaluria Type 1: A Retrospective Study.

Kidney medicine·2025
Same author

Long-term lumasiran therapy final results from a Phase 2 open-label extension study in primary hyperoxaluria.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2025
Same author

Navigating complex clinical decisions: kidney transplantation following abdominal aorto-aortic bypass in infantile Takayasu arteritis.

Pediatric nephrology (Berlin, Germany)·2025

Area of Science:

  • Nephrology
  • Hematology
  • Pediatric Medicine

Background:

  • Severe congenital neutropenia (SCN) is a rare condition requiring long-term treatment.
  • Granulocyte-colony stimulating factor (G-CSF) is a standard therapy for SCN, promoting neutrophil production.
  • Monitoring for potential long-term complications of G-CSF therapy is crucial.

Observation:

  • A pediatric patient with SCN on long-term G-CSF therapy presented with significant renal abnormalities.
  • Clinical manifestations included macroscopic hematuria, proteinuria, and declining kidney function.
  • Kidney biopsy confirmed membranoproliferative glomerulonephritis (MPGN) type I.

Findings:

  • The patient's renal symptoms improved upon temporary cessation of G-CSF and subsequent use of a glycosylated G-CSF formulation.

Related Experiment Videos

  • These findings suggest a potential causal link between G-CSF therapy and the development of MPGN.
  • The reversibility of renal manifestations indicates that G-CSF-induced nephropathy may occur.

    • Implications:

    • Long-term G-CSF therapy necessitates vigilant monitoring of renal function in patients with SCN.
    • Clinicians should consider G-CSF-induced nephropathy in patients with unexplained renal dysfunction.
    • Further research is warranted to elucidate the mechanisms of G-CSF-associated glomerulonephritis and optimize treatment strategies.